de Araujo DB

Advanced Research Center with Psychedelics, Federal University of Rio Grande do Norte, Natal, RN, Brazil; Brain Institute, Federal University of Rio Grande do Norte, Natal, RN, Brazil.

15 papers · 4 preprints · ORCID

ArticleKetamine

Exploratory non-randomized clinical trial of subcutaneous esketamine in treatment-resistant depression: Effects of ketamine-assisted psychotherapy.

Varela YM, Cavalcanti-Ribeiro P, de Sousa GM +18

Europe PMC2026
PreprintKetamine

Preliminary Non-Randomized Clinical Trial of Subcutaneous Esketamine in Treatment-Resistant Depression: Exploring Adjunctive Effects of Ketamine-Assisted Psychotherapy

Varela YM, Cavalcanti-Ribeiro P, de Sousa GM +18

Europe PMC2026
ArticlePsilocybin

Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics.

Varela YM, de O Tavares VD, Delgado LM +12

Europe PMC2026
ArticleKetamine

Inflammatory response to repeated subcutaneous esketamine in treatment-resistant depression: The role of baseline C-reactive protein.

Cavalcanti-Ribeiro P, De Souza LCAM, de Tavares VDO +11

Europe PMC2026
PreprintAyahuasca

Network Rerouting Under Ayahuasca: Temporally and Hemisphere-Resolved EEG Connectomics

Alves CL, Palhano-Fontes F, Toutain TGLdO +3

Europe PMC2025
ArticleKetamine

Ketamine's Altered States Meta-Analysis: The Relationship Between Psychomimetic and Clinical Effects With Focus in Depression.

Tavares VDO, da Costa Gonçalves KT, de Morais Barros ML +10

Europe PMC2025
ArticleKetamine

Ketamine-induced altered states of consciousness: a systematic review of implications for therapeutic outcomes in psychiatric practices.

da Costa Gonçalves KT, de Tavares VDO, de Morais Barros ML +9

Europe PMC2025
ArticleKetamine

Rapid and long-lasting effects of subcutaneous esketamine on suicidality: An open-label study in patients with treatment-resistant depression.

Lopes EITC, Cavalcanti-Ribeiro P, Palhano-Fontes F +7

Europe PMC2024
ArticleAyahuasca

Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study.

Arruda Sanchez T, Ramos LR, Araujo F +5

Europe PMC2024
ArticlePsilocybin

In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.

Luppi AI, Hansen JY, Adapa R +23

Europe PMC2023
ArticleAyahuasca

Moderators of ayahuasca's biological antidepressant action.

de Sousa GM, de Oliveira Tavares VD, de Menezes Galvão AC +10

Europe PMC2022
ArticleAyahuasca

Prophylactic action of ayahuasca in a non-human primate model of depressive-like behavior.

de Meiroz Grilo MLP, de Sousa GM, de Mendonça LAC +7

Europe PMC2022
PreprintPsilocybin

Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter Landscape

Luppi AI, Hansen JY, Adapa R +24

Europe PMC2022
ArticleAyahuasca

Characterizing Complex Networks Using Entropy-Degree Diagrams: Unveiling Changes in Functional Brain Connectivity Induced by Ayahuasca.

Viol A, Palhano-Fontes F, Onias H +3

Europe PMC2019
ArticleDMT

Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT.

Dakic V, Minardi Nascimento J, Costa Sartore R +5

Europe PMC2017
ArticleAyahuasca

Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.

Sampedro F, de la Fuente Revenga M, Valle M +14

Europe PMC2017
ArticleAyahuasca

Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca.

Viol A, Palhano-Fontes F, Onias H +2

Europe PMC2017
PreprintAyahuasca

Short term changes in the proteome of human cerebral organoids induced by 5-methoxy-N,N-dimethyltryptamine

Dakic V, Nascimento JM, Sartore RC +5

Europe PMC2017
ArticleAyahuasca

The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network.

Palhano-Fontes F, Andrade KC, Tofoli LF +5

Europe PMC2015